December 07, 2023
5 min watch
Save
VIDEO: National elimination plan heightens focus on HCV at The Liver Meeting
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON — In this video, Tatyana Kushner, MD, MSCE, discusses the “significant focus” at The Liver Meeting on the elimination of hepatitis C virus.
Kushner, associate professor of medicine at Icahn School of Medicine at Mount Sinai, noted this was likely due to the recent proposal from the Biden administration for a national HCV elimination plan.
“There was more hepatitis C-related content than I recall from prior years, which is exciting and great,” she said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Kushner reports serving on an advisory board for AbbVie, Bausch Health, Eiger, Gilead Sciences and GSK and receiving research support from Gilead Sciences
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.